When used in combination with GLP-1, which has glucose-lowering action, it has been shown to be an effective treatment for T2DM and obesity
Common GLP-1-based medications include: Semaglutide (brand names: Wegovy, Ozempic) Tirzepatide (brand names: Zepbound, Mounjaro) Retatrutide (currently an investigational medication and not yet FDA-approved for weight loss) These medications work best when combined with a healthy diet, regular physical activity, and sustainable lifestyle changes
Visualize Your Semaglutide Clearance Use the free GLP3Planner calculator to model how semaglutide levels decay after your last dose, then map your tirzepatide titration schedule from 2.5mg to your target dose
International Journal of Molecular Sciences, 21 (8), 2886
Its up to you and your physician to determine whether semaglutide is the right choice for your needs